HSBC Holdings’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
Other funds holding COLL
EAM
VCM
HSBC Holdings's COLL Position: Q1 2026 in Review
HSBC Holdings reduced its Collegium Pharmaceutical (COLL) stake by 11% in Q1 2026, selling an estimated $138K and leaving 27,594 shares worth $905K. The position accounts for ﹤0.01% of the portfolio, ranked #1924.
HSBC Holdings first reported a position in COLL in Q1 2021 and has held it in 16 quarters since. The position peaked at $1.43M in Q4 2025. 266 funds tracked by Wall St. Rank hold COLL as of Q1 2026.
- HSBC Holdings held 27,594 shares of Collegium Pharmaceutical worth $905K as of Q1 2026.
- HSBC Holdings sold 3,260 Collegium Pharmaceutical shares in Q1 2026, an estimated $138K.
- Collegium Pharmaceutical made up ﹤0.01% of HSBC Holdings's portfolio in Q1 2026, its #1924 holding.
- HSBC Holdings first reported a position in Collegium Pharmaceutical in Q1 2021 and has held it in 16 quarters since.
- HSBC Holdings's Collegium Pharmaceutical position peaked at $1.43M in Q4 2025.
- 266 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2026.
Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.